Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RZLT is expected to report earnings to rise 35.17% to -24 cents per share on February 11
Q4'25
Est.
$-0.24
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 512.77K shares outstanding, the current market capitalization sits at 927.28M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RZLT showed earnings on November 06, 2025. You can read more about the earnings report here.